Femasys Correlations
| FEMY Stock | USD 0.53 0.02 3.92% |
The current 90-days correlation between Femasys and Harvard Bioscience is -0.09 (i.e., Good diversification). The correlation of Femasys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Femasys Correlation With Market
Excellent diversification
The correlation between Femasys and DJI is -0.69 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Femasys Stock
| 0.65 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.72 | IHC | Inspiration Healthcare | PairCorr |
| 0.79 | NTI | Neurotech International | PairCorr |
| 0.7 | MLSS | Milestone Scientific | PairCorr |
Moving against Femasys Stock
| 0.77 | QIPT | Quipt Home Medical | PairCorr |
| 0.77 | 4DX | 4DMEDICAL | PairCorr |
| 0.7 | VMD | Viemed Healthcare | PairCorr |
| 0.47 | AMS | Advanced Medical Sol | PairCorr |
| 0.44 | IMDX | Insight Molecular Symbol Change | PairCorr |
| 0.74 | IMR | Imricor Medical Systems | PairCorr |
| 0.72 | TLT | Theralase Technologies | PairCorr |
| 0.72 | EYE | Nova EYE Medical | PairCorr |
| 0.68 | AFME | Affluent Medical SAS | PairCorr |
| 0.65 | AFW | Align Technology | PairCorr |
| 0.62 | CREO | Creo Medical Group | PairCorr |
| 0.54 | PINK | Perimeter Medical Imaging | PairCorr |
| 0.48 | PRN | Profound Medical Corp | PairCorr |
| 0.45 | MDX | MedX Health Corp | PairCorr |
| 0.42 | FPH | Fisher Paykel Healthcare Earnings Call This Week | PairCorr |
| 0.41 | POCI | Precision Optics Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Femasys Stock performing well and Femasys Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Femasys' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HBIO | 3.97 | (0.01) | 0.00 | 0.10 | 0.00 | 12.50 | 23.47 | |||
| COCH | 3.26 | (0.65) | 0.00 | (3.71) | 0.00 | 6.06 | 27.69 | |||
| AIMD | 4.48 | (0.89) | 0.00 | (0.21) | 0.00 | 12.30 | 38.73 | |||
| CRIS | 4.10 | (0.65) | 0.00 | (0.23) | 0.00 | 10.62 | 33.70 | |||
| DARE | 2.99 | (0.12) | 0.00 | (0.01) | 0.00 | 6.55 | 26.52 | |||
| EKSO | 6.23 | 1.37 | 0.23 | 0.61 | 5.58 | 10.72 | 112.11 | |||
| VVOS | 3.35 | (0.68) | 0.00 | (0.70) | 0.00 | 5.29 | 31.84 | |||
| PCSA | 8.26 | (0.74) | 0.00 | (55.86) | 0.00 | 11.68 | 164.28 | |||
| APLM | 6.20 | 0.71 | 0.10 | 0.91 | 6.60 | 17.08 | 44.38 | |||
| BCTX | 6.74 | (0.68) | 0.00 | (0.42) | 0.00 | 13.96 | 98.43 |
Femasys Corporate Management
| Steven Damon | VP Devel | Profile | |
| James MD | Chief Officer | Profile | |
| Richard Spector | Chief Officer | Profile | |
| Kelley Nicholas | Chief Officer | Profile | |
| Christine Thomas | Senior Affairs | Profile | |
| Dov Elefant | Chief Officer | Profile |